SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Goodwin Biotechnology, Inc. and MD Anderson Cancer Center Collaborate on the GMP Manufacturing of a Fusion Protein Conjugate that Potentially Represents a Critical Advance in Oncology